Clinical trial
A Comparative Study of KES524 in Patients With Obesity Disease
NCT00165685 · Eisai Limited, Industry · Completed
Key facts
| NCT number | NCT00165685 |
|---|---|
| Title | A Comparative Study of KES524 in Patients With Obesity Disease |
| Official title | A Double-Blind, Placebo-Controlled, Comparative Study of KES524 in Patients With Obesity Disease |
| Lead sponsor | Eisai Limited, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | Sibutramine Hydrochloride Monohydrate |
| Start date | Jul 1, 2004 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Sep 14, 2005 |
| Last update posted | Jan 29, 2010 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: